Serum hyaluronan as a marker reflecting the severity of cirrhosis and portal hypertension in postoperative biliary atresia

Pediatric Surgery International

Volumn 20, Issue 10, 2004, Pages 773-777

  Chongsrisawat, Voranush ^a   Kongtawelert, Prachya ^b   Tongsoongnoen, Wannarat ^b   Tangkijvanich, Pisit ^a   Vejchapipat, Paisarn ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Biliary atresia; Cirrhosis; Hyaluronan; Portal hypertension

Indexed keywords

BIOCHEMICAL MARKER; HYALURONIC ACID;

ADOLESCENT; ADULT; ARTICLE; ASCITES; BILE DUCT ATRESIA; BLEEDING; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS VARICES; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ASCITES; ASPARTATE AMINOTRANSFERASES; BILIARY ATRESIA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYALURONIC ACID; HYPERTENSION, PORTAL; INFANT; LIVER CIRRHOSIS; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

EID: 11244308219     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-004-1141-7     Document Type: Article

References (26)

1. Lefkowitch JH (1998) Biliary atresia. Mayo Clin Proc 73:90-95
2. Karrer FM, Price MR, Bensard DD, et al. (1996) Long-term results with the Kasai operation for biliary atresia. Arch Surg 131:493-496
3. Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER (1997) Biliary atresia: the King's College Hospital experience (1974-1995). J Pediatr Surg 32:479-485
4. Kasai M, Mochizuki I, Ohkohchi N, et al. (1989) Surgical limitation for biliary atresia: indication for liver transplantation. J Pediatr Surg 24:851-854
5. Laurent J, Gauthier F, Bernard O, et al. (1990) Long-term outcome after surgery for biliary atresia. Gastroenterology 99:1793-1797
6. Miyano T, Fujimoto T, Ohya T, et al. (1993) Current concept of the treatment of biliary atresia. World J Surg 17:332-336
7. Laurent TC, Fraser JR (1992) Hyaluronan. FASEB J 6:2397-2404
8. Gressner AM, Schafer S (1989) Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells. J Clin Chem Clin Biochem 27:141-149
9. Lebel L, Gabrielsson J, Laurent TC, Gerdin B (1994) Kinetics of circulating hyaluronan in humans. 4. Eur J Clin Invest 24:621-626
10. Oberti F, Valsesia E, Pilette C, et al. (1997) Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113:1609-1616
11. Pares A, Deulofeu R, Gimenez A, et al. (1996) Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 24:1399-1403
12. Korner T, Kropf J, Gressner AM (1996) Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 25:684-688
13. Infante-Rivard C, Esnaola S, Villeneuve J (1987) Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7:660-664
14. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
15. Kongtawelert P, Ghosh P (1990) A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem 185:313-318
16. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250
17. Guechot J, Poupon RE, Poupon R (1995) Serum hyaluronan as a marker of liver fibrosis. J Hepatol 22:103-106
18. Guechot J, Serfaty L, Bonnand AM, Chazouilleres O, Poupon RE, Poupon R (2000) Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 32:447-452
19. Trivedi P, Cheeseman P, Mowat AP (1993) Serum hyaluronic acid in healthy infants and children and its value as a marker of progressive hepatobiliary disease starting in infancy. Clin Chim Acta 215:29-39
20. Hasegawa T, Sasaki, Kimura T, et al. (2000) Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. J Pediatr Surg 35:1643-1646
21. Kobayashi H, Horikoshi K, Yamataka A, et al. (1999) Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia. J Pediatr Surg 34:1791-1794
22. Dhawan A, Trivedi P, Cheeseman P, Baker AJ, Howard ER, Mieli-Vergani G (2001) Serum hyaluronic acid as an early prognostic marker in biliary atresia. J Pediatr Surg 36:443-446
23. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H (1996) Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 11:459-465
24. Nyberg A, Engstrom-Laurent A, Loof L (1988) Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology 8:142-146
25. Takei S, Imanaka H, Maeno N, et al. (1996) Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis. J Rheumatol 23:1956-1962
26. Trivedi P, Dhawan A, Risteli J, et al. (1995) Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia. Pediatr Res 38:568-573